Agency Information Collection Activities: Proposed Collection; Comment Request, 38208-38209 [E9-18378]
Download as PDF
PWALKER on DSK8KYBLC1PROD with NOTICES
38208
Federal Register / Vol. 74, No. 146 / Friday, July 31, 2009 / Notices
400. (For policy questions regarding this
collection contact JoAnn Cerne at 410–
786–4530. For all other issues call 410–
786–1326.)
4. Type of Information Collection
Request: Revision of a currently
approved Collection; Title of
Information Collection: Home Health
Advance Beneficiary Notice (HHABN);
Use: Home health agencies (HHAs) are
required to provide written notice to
Medicare beneficiaries under various
circumstances involving the initiation,
reduction, or termination of services.
The vehicle used in these situations is
the Home Health Advance Beneficiary
Notice (HHABN). The notice is designed
to ensure that beneficiaries receive
complete and useful information
regarding potential financial liability or
any changes made to their plan of care
(POC) to enable them to make informed
consumer decisions. The notice must
provide clear and accurate information
about the specified services and, when
applicable, the cost of services when
Medicare denial of payment is expected
by the HHA. Form Number: CMS–R–296
(OMB#: 0938–0781); Frequency:
Reporting—Hourly, Daily, Weekly,
Monthly, Yearly, Quarterly, Semiannually, Biennially, Once and
Occasionally; Affected Public: Business
or other for-profits and Not-for-profit
institutions; Number of Respondents:
9024; Total Annual Responses:
12,349,787; Total Annual Hours:
1,028,737. (For policy questions
regarding this collection contact Evelyn
Blaemire at 410–786–1803. For all other
issues call 410–786–1326.)
To obtain copies of the supporting
statement and any related forms for the
proposed paperwork collections
referenced above, access CMS Web Site
address at https://www.cms.hhs.gov/
PaperworkReductionActof1995, or Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov, or call the
Reports Clearance Office on (410) 786–
1326.
To be assured consideration,
comments and recommendations for the
proposed information collections must
be received by the OMB desk officer at
the address below, no later than 5 p.m.
on August 31, 2009.
OMB, Office of Information and
Regulatory Affairs, Attention: CMS
Desk Officer, Fax Number: (202) 395–
6974, e-mail:
OIRA_submission@omb.eop.gov.
VerDate Nov<24>2008
16:38 Jul 30, 2009
Jkt 217001
Dated: July 23, 2009.
Michelle Shortt,
Director, Regulations Development Group,
Office of Strategic Operations and Regulatory
Affairs.
[FR Doc. E9–18379 Filed 7–30–09; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10191]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
AGENCY: Centers for Medicare &
Medicaid Services, HHS.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS) is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Medicare Parts
C and D Universal Audit Guide; Use:
Under the Medicare Prescription Drug,
Improvement, and Modernization Act of
2003 and implementing regulations at
42 CFR Parts 422 and 423 Medicare Part
D plan sponsors and Medicare
Advantage organizations are required to
comply with all Medicare Parts C and D
program requirements. 42 CFR 422.502
describes CMS’ regulatory authority to
evaluate, through inspection or other
means, Medicare Advantage Part C
organizations. These records include
books, contracts, medical records,
patient care documentation and other
records that pertain to any aspect of
services performed, reconciliation of
benefit liabilities, and determination of
amounts payable. 42 CFR 423.503 states
that CMS must oversee a Part D plan
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
sponsor’s continued compliance with
the requirements for a Part D plan
sponsor. § 423.514 states that the Part D
plan sponsor must have an effective
procedure to develop, compile,
evaluate, and report to CMS, to its
enrollees, and to the general public, at
the times and in the manner that CMS
requires, statistics regarding areas such
as cost of operations, patterns of
utilization availability, accessibility,
and acceptability of services.
The explosive growth of these
sponsoring organizations has forced
CMS to update its current auditing
strategy to ensure we continue to obtain
meaningful audit results. As a result,
CMS’ audit strategy will reflect a move
away from routine audits to more
targeted, data-driven and risk-based
audits. CMS will also focus on high-risk
areas that have the greatest potential for
beneficiary harm. The goal of the audits
will be the earliest possible detection
and correction of issues and
improvement in quality and
performance of Part D sponsors and
Medicare Advantage organizations.
To accomplish these goals, we have
combined all Part C and Part D audit
elements into one universal guide
which will also promote consistency,
effectiveness and reduce financial and
time burdens for both CMS and
Medicare-contracting entities. Please
refer to the crosswalk document for a
list of changes. Form Number: CMS–
10191 (OMB#: 0938–1000); Frequency:
Reporting—Yearly; Affected Public:
Business or other for-profits and Notfor-profit institutions; Number of
Respondents: 195; Total Annual
Responses: 195; Total Annual Hours:
24,180. (For policy questions regarding
this collection contact Laura Dash at
410–786–8623. For all other issues call
410–786–1326).
To obtain copies of the supporting
statement and any related forms for the
proposed paperwork collections
referenced above, access CMS’ Web Site
at https://www.cms.hhs.gov/
PaperworkReductionActof1995, or Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov, or call the
Reports Clearance Office on (410) 786–
1326.
In commenting on the proposed
information collections please reference
the document identifier or OMB control
number. To be assured consideration,
comments and recommendations must
be submitted in one of the following
ways by September 29, 2009:
1. Electronically. You may submit
your comments electronically to https://
www.regulations.gov. Follow the
E:\FR\FM\31JYN1.SGM
31JYN1
Federal Register / Vol. 74, No. 146 / Friday, July 31, 2009 / Notices
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) accepting comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number (CMS–10078), Room
C4–26–05, 7500 Security Boulevard,
Baltimore, Maryland 21244–1850.
Dated: July 23, 2009.
Michelle Shortt,
Director, Regulations Development Group,
Office of Strategic Operations and Regulatory
Affairs.
[FR Doc. E9–18378 Filed 7–30–09; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2009–N–0352]
Preparation for International
Cooperation on Cosmetics
Regulations Meetings in Tokyo, Japan;
Public Meeting
AGENCY:
Food and Drug Administration,
HHS.
PWALKER on DSK8KYBLC1PROD with NOTICES
ACTION:
Notice of public meeting.
SUMMARY: The Food and Drug
Administration (FDA) is announcing a
public meeting entitled ‘‘International
Cooperation on Cosmetics Regulations
(ICCR)—Preparation for ICCR—3
Meetings in Tokyo, Japan’’ to provide
information and receive comments on
the International Cooperation on
Cosmetics Regulations (ICCR) as well as
the upcoming meetings in Tokyo, Japan.
The topics to be discussed are the topics
for discussion at the forthcoming ICCR
steering committee meeting. The
purpose of the meeting is to solicit
public input prior to the next steering
committee and expert working group
meetings in Tokyo, Japan, scheduled for
the week of September 7, 2009.
Date and Time: The meeting will be
held on September 2, 2009, from 1:30
p.m. to 3 p.m.
Location: The meeting will be held in
University Station, rm. 2073, 4300 River
Rd., College Park, MD 20740.
Contact Person: All participants must
register with Mary Morrison, Office of
the Commissioner (HFG–1), Food and
Drug Administration, 5600 Fishers
Lane, Rockville, MD 20857, e-mail:
mary.morrison@fda.hhs.gov, FAX: 301–
827–0003.
VerDate Nov<24>2008
16:38 Jul 30, 2009
Jkt 217001
Registration and Requests for Oral
Presentations: Send registration
information (including name, title, firm
name, address, telephone, and fax
number), written material and requests
to make oral presentation, to the contact
person by August 30, 2009.
If you need special accommodations
due to a disability, please contact Mary
Morrison (see Contact Person) at least 7
days in advance.
Transcripts: Please be advised that as
soon as a transcript is available, it will
be accessible at https://
www.regulations.gov. It may be viewed
at the Division of Dockets Management
(HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD. A transcript will
also be available in either hardcopy or
on CD–ROM, after submission of a
Freedom of Information request. Written
requests are to be sent to the Division
of Freedom of Information (HFI–35),
Office of Management Programs, Food
and Drug Administration, 5600 Fishers
Lane, rm. 6–30, Rockville, MD 20857.
SUPPLEMENTARY INFORMATION: The
purpose of the multilateral framework
on the ICCR is to pave the way for the
removal of regulatory obstacles to
international trade while maintaining
global consumer protection.
ICCR is a voluntary international
group of cosmetics regulatory
authorities from the United States,
Japan, the European Union, and Canada.
These regulatory authority members
will enter into constructive dialogue
with their relevant cosmetics’ industry
trade associations. Currently, the ICCR
members are Health Canada; the
European Directorate General for
Enterprise and Industry; the Ministry of
Health, Labor and Welfare of Japan; and
the U.S. Food and Drug Administration.
All decisions made by the consensus
will be compatible with the laws,
policies, rules, regulations, and
directives of the respective
administrations and governments.
Members will implement and/or
promote actions or documents within
their own jurisdictions and seek
convergence of regulatory policies and
practices. Successful implementation
will require input from stakeholders.
Interested persons may present data,
information, or views orally or in
writing, on issues pending at the public
meeting. Time allotted for oral
presentations may be limited to 10
minutes. Those desiring to make oral
presentations should notify the contact
person by August 30, 2009, and submit
a brief statement of the general nature of
the evidence or arguments they wish to
present, the names and addresses,
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
38209
telephone number, fax, and e-mail of
proposed participants, and an
indication of the approximate time
requested to make their presentation.
The agenda for the public meeting
will be made available on the Internet
at https://www.fda.gov/Cosmetics/
InternationalActivities/
ConferencesMeetingsWorkshops/
InternationalCooperationonCosmetics
RegulationsICCR/default.htm.
Dated: July 27, 2009.
Jeffrey Shuren,
Associate Commissioner for Policy and
Planning.
[FR Doc. E9–18321 Filed 7–30–09; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Insulin Binding and
Signaling.
Date: August 20, 2009.
Time: 1:30 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call)
Contact Person: Lakshmanan Sankaran,
PhD, Scientific Review Officer, Review
Branch, DEA, NIDDK, National Institutes of
Health, Room 755, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452, (301)
594–7799, ls38z@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Immunology in
Liver Disease.
E:\FR\FM\31JYN1.SGM
31JYN1
Agencies
[Federal Register Volume 74, Number 146 (Friday, July 31, 2009)]
[Notices]
[Pages 38208-38209]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-18378]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[Document Identifier: CMS-10191]
Agency Information Collection Activities: Proposed Collection;
Comment Request
AGENCY: Centers for Medicare & Medicaid Services, HHS.
In compliance with the requirement of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the Centers for Medicare & Medicaid
Services (CMS) is publishing the following summary of proposed
collections for public comment. Interested persons are invited to send
comments regarding this burden estimate or any other aspect of this
collection of information, including any of the following subjects: (1)
The necessity and utility of the proposed information collection for
the proper performance of the agency's functions; (2) the accuracy of
the estimated burden; (3) ways to enhance the quality, utility, and
clarity of the information to be collected; and (4) the use of
automated collection techniques or other forms of information
technology to minimize the information collection burden.
1. Type of Information Collection Request: Revision of a currently
approved collection; Title of Information Collection: Medicare Parts C
and D Universal Audit Guide; Use: Under the Medicare Prescription Drug,
Improvement, and Modernization Act of 2003 and implementing regulations
at 42 CFR Parts 422 and 423 Medicare Part D plan sponsors and Medicare
Advantage organizations are required to comply with all Medicare Parts
C and D program requirements. 42 CFR 422.502 describes CMS' regulatory
authority to evaluate, through inspection or other means, Medicare
Advantage Part C organizations. These records include books, contracts,
medical records, patient care documentation and other records that
pertain to any aspect of services performed, reconciliation of benefit
liabilities, and determination of amounts payable. 42 CFR 423.503
states that CMS must oversee a Part D plan sponsor's continued
compliance with the requirements for a Part D plan sponsor. Sec.
423.514 states that the Part D plan sponsor must have an effective
procedure to develop, compile, evaluate, and report to CMS, to its
enrollees, and to the general public, at the times and in the manner
that CMS requires, statistics regarding areas such as cost of
operations, patterns of utilization availability, accessibility, and
acceptability of services.
The explosive growth of these sponsoring organizations has forced
CMS to update its current auditing strategy to ensure we continue to
obtain meaningful audit results. As a result, CMS' audit strategy will
reflect a move away from routine audits to more targeted, data-driven
and risk-based audits. CMS will also focus on high-risk areas that have
the greatest potential for beneficiary harm. The goal of the audits
will be the earliest possible detection and correction of issues and
improvement in quality and performance of Part D sponsors and Medicare
Advantage organizations.
To accomplish these goals, we have combined all Part C and Part D
audit elements into one universal guide which will also promote
consistency, effectiveness and reduce financial and time burdens for
both CMS and Medicare-contracting entities. Please refer to the
crosswalk document for a list of changes. Form Number: CMS-10191
(OMB: 0938-1000); Frequency: Reporting--Yearly; Affected
Public: Business or other for-profits and Not-for-profit institutions;
Number of Respondents: 195; Total Annual Responses: 195; Total Annual
Hours: 24,180. (For policy questions regarding this collection contact
Laura Dash at 410-786-8623. For all other issues call 410-786-1326).
To obtain copies of the supporting statement and any related forms
for the proposed paperwork collections referenced above, access CMS'
Web Site at https://www.cms.hhs.gov/PaperworkReductionActof1995, or E-
mail your request, including your address, phone number, OMB number,
and CMS document identifier, to Paperwork@cms.hhs.gov, or call the
Reports Clearance Office on (410) 786-1326.
In commenting on the proposed information collections please
reference the document identifier or OMB control number. To be assured
consideration, comments and recommendations must be submitted in one of
the following ways by September 29, 2009:
1. Electronically. You may submit your comments electronically to
https://www.regulations.gov. Follow the
[[Page 38209]]
instructions for ``Comment or Submission'' or ``More Search Options''
to find the information collection document(s) accepting comments.
2. By regular mail. You may mail written comments to the following
address: CMS, Office of Strategic Operations and Regulatory Affairs,
Division of Regulations Development, Attention: Document Identifier/OMB
Control Number (CMS-10078), Room C4-26-05, 7500 Security Boulevard,
Baltimore, Maryland 21244-1850.
Dated: July 23, 2009.
Michelle Shortt,
Director, Regulations Development Group, Office of Strategic Operations
and Regulatory Affairs.
[FR Doc. E9-18378 Filed 7-30-09; 8:45 am]
BILLING CODE 4120-01-P